Gestational carrier use in assisted reproductive technology: what can it tell us about the uterine role in infertility?
In this issue, Dr. Gayathree Murugappan and colleagues (1) provide a detailed analysis of 10 years of Society for Assisted Reproductive Technology (SART) data on gestational carrier and nongestational carrier (autologous uterus) assisted reproductive technology (ART) cycle outcomes. Over the 10 years, SART reported 1,337,721 cycles that met their inclusion criteria, of which 24,269 (1.81%) used a gestational carrier’s uterus. In brief, the authors found that use of a gestational carrier uterus during ART cycles resulted in statistically significantly better implantation, clinical pregnancy, and live-birth rates as compared with the use of an autologous uterus.
Source: fertstert.org
Gestational carrier use in assisted reproductive technology: what can it tell us about the uterine role in infertility?
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Characterization of the stem cell niche components within the seminiferous tubules in testicular biopsies of Klinefelter patients
Be First to Comment